Risk factors and outcome of COVID-19 in patients with hematological malignanciesJosé Luís Piñana, Anna Sureda, Rodrigo Martino et al.|Experimental Hematology and Oncology|2020Cited by 159
A novel targeted RNA-Seq panel identifies a subset of adult patients with acute lymphoblastic leukemia with BCR-ABL1-like characteristicsRicardo Sánchez, Joaquín Martínez‐López, Marta Cervera et al.|Blood Cancer Journal|2020Cited by 23
Detection of kinase domain mutations in BCR::ABL1 leukemia by ultra-deep sequencing of genomic DNARicardo Sánchez, Joaquín Martínez‐López, Sara Dorado et al.|Scientific Reports|2022Cited by 12
Prognostic heterogeneity of adult B‐cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/<i>TCF3‐PBX1</i> treated with measurable residual disease‐oriented protocolsJordi Ribera, Isabel Granada, Mireia Morgades et al.|British Journal of Haematology|2021Cited by 7
Salvage Therapy with Second-Generation Inhibitors for FLT3 Mutated Acute Myeloid Leukemia: A Real-World Study by the CETLAM and PETHEMA GroupsSusana Vives, Pau Montesinos, David Quintela et al.|Cancers|2024Cited by 4